mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |